This test yields a intermediate resolution DRB1 result with low to intermediate resolution DRB3, 4, and 5. Test can be used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).